In vitro metabolism of quinidine: The (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 31-37

  Nielsen, Torben Leo ^b   Rasmussen, Birgitte Buur ^c   Flinois, Jean Pierre ^a   Beaune, Philippe ^a   Brøsen, Kim ^c  

^a INSERM   (France)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; BIFONAZOLE; BROMOCRIPTINE; CYCLOSPORIN A; CYTOCHROME P450; DIHYDROERGOTAMINE; ERYTHROMYCIN; ETHINYLESTRADIOL; FELODIPINE; FLUCONAZOLE; GESTODENE; ITRACONAZOLE; KETOCONAZOLE; MIDAZOLAM; NARINGENIN; NEFAZODONE; NIFEDIPINE; NITRENDIPINE; PACLITAXEL; QUINIDINE; TERFENADINE; TROLEANDOMYCIN; VINBLASTINE; VINCRISTINE;

ARTICLE; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG OXIDATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL;

EID: 0032947029     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Andersson T, Miners JO, Veronese ME and Birkett DJ (1994) Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A4 isoforms. Br J Clin Pharmacol 38:131-137.
2. Back DJ and Tjia JF (1991) Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br J Clin Pharmacol 32:624-626.
3. Belloc C, Baird S, Cosme J, Lecoeur S, Gautier JC, Challine D, de Waziers I, Flinois JP and Beaune PH (1996) Human cytochromes P450 expressed in Escherichia coli: Production of specific antibodies. Toxicology 106:207-219.
4. Cullin C and Pompon D (1988) Synthesis of functional mouse cytochromes P-450 P1 and chimeric P-450 P3-1 in the yeast Saccharomyces cerevisiae. Gene 65:203-217.
5. Gallagher EP, Kunze KL, Stapleton PL and Eaton DL (1996) The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 141:595-606.
6. Gautier JC, Lecoeur S, Cosme J, Perret A, Urban P, Beaune P and Pompon D (1996) Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast. Pharmacogenetics 6:489-499.
7. Guengerich FP (1990) Mechanism-based inactivation of human liver microsomal cytochrome P450 IIIA4 by gestodene. Chem Res Toxicol 3:363-371.
8. Guengerich FP, Müller-Enoch D and Blair IA (1986) Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 30:287-295.
9. Iribarne C, Berthou F, Baird S, Dréano Y, Picart D, Bail JP, Beaune PH and Ménez JF (1996) Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 9:365-373.
10. Jeppesen U, Rasmussen BB and Brøsen K (1997) Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide. Clin Pharmacol Ther 62:279-286.
11. Kaukonen KM, Olkkola KT and Neuvonen PJ (1997) Itraconazole increases plasma concentrations of quinidine. Clin Pharmacol Ther 62:510-517.
12. Kerlan V, Dreano Y, Bercovici JP, Beaune P, Floch HH and Berthou F (1992) Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem Pharmacol 44:1745-1756.
13. Kremers P, Beaune P, Cresteil T, de Graeve J, Columelli S, Leroux JP and Gielen JE (1981) Cytochrome P-450 monooxygenase activities in human and rat liver microsomes. Eur J Biochem 118:599-606.
14. Kroboth PD, Folan MM, Lush RM, Chaikin PC, Shukla UA, Barbhaiya R and Salazar DE (1995) Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment. J Clin Psychopharmacol 15:306-319.
15. Laemmli, UK (1970) Change of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Lemoine A, Gautier JC, Azoulay D, Kiffel L, Belloc C, Guengerich FP, Maurel P, Beaune P and Leroux JP (1993) Major pathway of imipramine metabolism is catalyzed by cytochrome P-450 1A2 and P-450 3A4 in human liver. Mol Pharmacol 43:827-832.
17. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA and Watkins PB (1994) Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Drug Metab Dispos 22:947-955.
18. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ (1951) Protein measurement with pholin phenol reagent. J Biol Chem 193:265-275.
19. Meier PJ, Mueller HK, Dick B and Meyer UA (1983) Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation. Gastroenterology 85:682-692.
20. Nielsen F, Nielsen KK and Brøsen K (1994) Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography. J Chromat B 660:103-110.
21. Nielsen F, Rosholm J-U and Brosen K (1995) Lack of relationship between quinidine pharmacokinetics and the sparteine oxidation polymorphism. Eur J Clin Pharmacol 48:501-504
22. Nielsen KK, Flinois JP, Beaune P and Brøsen K (1996) The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. J Pharmacol Exp Ther 277:1659-1664.
23. Omura T and Sato R (1964) The carbon monoxide binding pigment of liver microsomes. J Biol Chem 239:2370-2385.
24. Peyronneau M, Renaud JP, Truan G, Urban P, Pompon D and Mansuy D (1992) Optimization of yeast-expressed human liver cytochrome P-450 3A4 catalytic activities by coexpressing NADPH-cytochrome P-450 and cytochrome b5. Eur J Biochem 207:109-116.
25. Pompon D, Louerat B, Bronine A and Urban P (1996) Yeast expression of animal and plant P450s in optimized redox environments. Methods Enzymol 272:51-64.
26. Schmider J, Greenblatt DJ, Harmatz JS and Shader RI (1996) Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: Application to amitriptyline N-demethylation. Br J Clin Pharmacol 41:593-604.
27. Shou M, Grogan J, Mancewicz JA, Krause KW, Gonzalez FJ, Gelboin HV and Korzekwa KR (1994) Activation of CYP3A4: Evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 33:6450-6455.
28. Srivastava PK, Beaune PH, Ged C and Guengerich FP (1991) Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4′-hydroxylase cytochrome P450 enzymes. Mol Pharmacol 40:69-79.
29. Spinler SA, Cheng JWM, Kindwall KE and Charland SL (1995) Possible inhibition of hepatic metabolism of quinidine by erythromycin. Clin Pharmacol Ther 57:89-94.
30. Towbin H, Staehelin T and Gordon J (1979) Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
31. Ueng YF, Kuwabara T, Chun YJ and Guengerich FP (1997) Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry 36:370-381.
32. Urban P, Cullin C and Pompon D (1990) Maximizing the expression of mammalian cytochromes P-450 monooxygenase activities in yeast cells. Biochimie 72:463-472.
33. Varhe A, Olkkola KT and Neuvonen P (1996) Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism. Br J Clin Pharmacol 41:319-323.
34. von Moltke LL, Greenblatt DJ, Schmider J, Harmatz JS and Shader RI (1995) Metabolism of drugs by cytochrome P450 3A isoforms. Clin Pharmacokinet 29:33-44.
35. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molawa DT and Vandenbranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (Hlp3). Mol Pharmacol 38:207-213.
36. Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S and Ishizaki T (1996) Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human liver microsomes and nine recombinant human cytochromes P450. J Pharmacol Exp Ther 279:1327-1334.
37. Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P and Ranmani R (1993) Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Biochem Pharmacol 45:853-861.